Biomeditsina va amaliyot jurnali, 2022 №4

Maqola mavzusi

SIGNIFICANCE OF EXPRESSION OF PD-L1 AND P53 PROTEINS IN HUMAN PAPILLOMAVIRUS-ASSOCIATED OROPHARYNGEAL SQUAMOUS CELL CARCINOMA (144-151)

Mualliflar

ПОЛАТОВА Джамила Шагайратовна Доктор медицинских наук (DMSc), доцент МАДАМИНОВ Ахмад Юлдашевич Республиканский специализированный научно-практический медицинский центр онкологии и радиологии РАХИМОВ Нодир Махамматкулович Доктор медицинских наук (DMSc), доцент Самаркандский Государственный медицинский университет

Muassasa

Tibbiyot fanlari doktori, dotsent Samarqand Davlat tibbiyot universiteti

Annotatsiya

Yuqori xavfdagi odam papilloma virusi (OPV) ogiz-halqum yassi hujayrali karsinomasini (OHYHK) keltirib chiqarib, asosan bodomsimon bezlarning va til asosining limfoid to'qimalaridan kelib chiqadigan o'smalarning taxminan 70% da aniqlanadi. Tadqiqotga 2015-2020-yillarda Respublika ixtisoslashtirilgan onkologiya va radiologiya ilmiy-amaliy tibbiyot markazi va uning Toshkent shahar filialida davolangan T1-4N0-3M0 (AJCC, 7-nashr) OHYHK bilan kasallangan 76 nafar bemor ishtirok etdi. 30ta tanlangan bemorlar gistologik preparatlari uchta molekulyar markerlarning P16INK4a, PDL1 va p53 ekspressiyasi IGK yordamida baholandi. p16INK4a ning yuqori ekspressiyasi 46% (6/13) da ijobiy PD-L1 reaktsiyasi bilan birga kuzatildi va p53 mutant turining ijobiy ifodasi kuzatilmadi. Shuni ta'kidlash kerakki, p53 tabiy turi p16INK4a ning haddan tashqari ifodalanishi bilan birgalikda faqat 1 holatda (3%) aniqlandi. OHYHK molekulyar profilini aniqlash uning biologik xususiyatlarini yaxshiroq tushunishga yordam beradi, bundan tashqari, u kasalliklarning oldini olish va samarali davolashda muhim rol o'ynaydi. Kalit so'zlar: Ogiz-halqum yassi hujayrali karsinomasi, odam papilloma virusi, immunogistokimyo, molekulyar marker, oqsil ekspressiyasi, p16INK4a, PD-L1, p53.

Kalit so'zlar

Kalit so'zlar: Ogiz-halqum yassi hujayrali karsinomasi, odam papilloma virusi, immunogistokimyo, molekulyar marker, oqsil ekspressiyasi, p16INK4a, PD-L1, p53.

Adabiyotlar

1. Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K., & Elinav, E. Microbiome and cancer //Cancer Cell – 2021, 11;39(10):1317-1341. 2. Bravo, I.G., Félez-Sánchez, M. Papillomaviruses: Viral evolution, cancer and evolutionary medicine //Evol. Med. Pub. Health – 2015;(1), 32-51. 3. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma //J Clin Oncol – 2015, 10;33(29):3235-42. 4. Castellsagué X, Alemany L, Quer M, Halec G, Quirós B, Tous S, Clavero O, Alòs L, Biegner T, Szafarowski T,... Xavier Bosch F. ICO International HPV in Head and Neck Cancer Study Group. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients //J Natl Cancer Inst. 2016, 28;108(6). 5. Мудунов А.М. Вирус папилломы человека – новый этиологический фактор в развитии рака органов головы и шеи. Проблемы и перспективы их решения //Эпидемиология и Вакцинопрофилактика – 2018, 17 (5): 100-105. 6. Pan C., Issaeva N., Yarbrough W.G. HPV-driven oropharyngeal cancer: current knowledge of molecular biology and mechanisms of carcinogenesis //Cancers Head Neck – 2018, 3;12. 7. Cosper PF, Bradley S, Luo L, Kimple RJ. Biology of HPV Mediated Carcinogenesis and Tumor Progression //Semin Radiat Oncol. 2021, 31(4):265-273. 8. Vande Pol SB, Klingelhutz AJ. Papillomavirus E6 oncoproteins //Virology – 2013, 445(1- 2):115-137. 9. Lewis JS, Jr.., Beadle B, Bishop JA, Chernock RD, Colasacco C, Lacchetti C, Moncur JT, Rocco JW, Schwartz MR, Seethala RR, Thomas NE, Westra WH, Faquin WC. Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists //Arch Pathol Lab Med. 2018;142(5):559–97. 10. Budu VA, Decuseară T, Balica NC, Mogoantă CA, Rădulescu LM, Chirilă M, Maniu AA, Mistra DM, Muşat GC, Oprişcan IC, Georgescu MG. The role of HPV infection in oropharyngeal cancer //Rom J Morphol Embryol. 2019;60(3):769-773. 11. E. Munari, F.R. Mariotti, L. Quatrini, P. Bertoglio, N. Tumino, P. Vacca, A. Eccher, F. Ciompi, M. Brunelli, G. Martignoni, G. Bogina, L. Moretta, PD-1/PD-L1 in cancer: pathophysiological, diagnostic and therapeutic aspects //Int. J. Mol. Sci. 2021, 22;5123. 12. Salmaninejad, A., Khoramshahi, V., Azani, A., Soltaninejad, E., Aslani, S., Zamani, MR. et al. PD-1 and cancer: molecular mechanisms and polymorphisms //Immunogenetics – 2017;70(2), 73–86. 13. Mittal, S. & Banks, L. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation //Mutat. Res. 2017;772, 23–35. 14. Dogan, S. et al. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPVnegative squamous cell carcinomas of the oropharynx //Int. J. Cancer – 2019;145, 3152–3162. 15. Wagner S, Prigge ES, Wuerdemann N, Reder H, Bushnak A, Sharma SJ, Obermueller T, von Knebel Doeberitz M, Dreyer T, Gattenlöhner S, Wolf G, Pons-Kühnemann J, Wittekindt C, Klussmann JP. Evaluation of p16INK4a expression as a single marker to select patients with HPV-driven oropharyngeal cancers for treatment de-escalation //Br J Cancer – 2020;123(7):1114-1122.